Abbott Hosts Conference Call for Fourth-Quarter and Full-Year 2014 Earnings

ABBOTT PARK, Ill., Jan. 8, 2015 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its fourth-quarter and full-year 2014 financial results on Thursday, Jan. 29, 2015, before the market opens. 

The announcement will be followed by a live webcast of the earnings conference call at 8 a.m. Central time (9 a.m. Eastern), and will be accessible through Abbott's Investor Relations website at www.abbottinvestor.com. An archived edition of the call will be available after 11 a.m. Central time.

About Abbott

Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. With a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals, Abbott serves people in more than 150 countries and employs approximately 69,000 people.

Visit Abbott at www.abbott.com and connect with us on Twitter at @AbbottNews.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/abbott-hosts-conference-call-for-fourth-quarter-and-full-year-2014-earnings-300017618.html

SOURCE Abbott

Suggested Articles

Only months removed from a gamechanging label expansion for Vascepa, Amarin is scrambling after a district judge invalidated the drug's key patents.

Move over, Roche. There’s a new small-cell lung cancer therapy on the scene, and it belongs to AstraZeneca.

Fujifilm says it is prepared to ramp up production of Avigan for any country that wants to try it as a potential treatment for COVID-19.